Abstract:Introduction - Inherited antithrombin III deficiency is an autosomal dominant genetic disease, which can lead to various forms of thrombus and is associated with pathological pregnancy. Methods - In this study, we reported a familial pedigree with three daughters diagnosed as AT III deficiency with different clinical manifestations. The first one was diagnosed with deep vein thrombus (DVT) during pregnancy and developed into acute pulmonary embolism (PE) under anticoagulation of low molecular heparin. The second one developed unprovoked DVT in left lower extremity and received the treatment of inferior vena filter, catheter-directed thrombolysis, pharmacomechanical thrombectomy and anticoagulation with rivaroxaban. The last one experienced an abortion because of placental abruption in the second trimester of pregnancy and the pathology indicated thrombosis in the microvessels of the placenta. We screened the whole family members for AT activity and antigen level, including the patients’ parents and sister without venous thromboembolism (VTE) history. Whole exome sequencing was performed in the first case to identify variations in the AT gene and Sanger sequencing was further adopted for other family members to verify the gene mutation responsible for the pedigree. We also conducted a long-term follow up of this family to help them with the anticoagulation during pregnancy and daily life. Results - Four members of the family, including the three sick daughters and their father, showed a deceased AT III activity and antigen level. However, their father did not have any VTE history before. The whole exome sequencing identified three nonsynonymous mutations, including c.1273C>T(p.R425C) mutation in SERPINC1, c.1200A>C(p.E400D) mutation in SERPINA1 and c.494C>T(p.T165M) mutation in F2. Then the Sanger sequencing for other family members verified the first mutation, c.1273C>T(p.R425C) mutation in SERPINC1, was the pathogenic gene for this family because of the consistence of mutation and decreased AT III activity. During the 2-year follow up, the father was attacked by DVT and two of the sick daughters gave birth to a healthy baby respectively with anticoagulation during pregnancy. Conclusion - Inherited antithrombin III deficiency is a hypercoagulable state associated with an increased risk for venous thrombosis, which cannot be relieved by low molecular heparin except NOACs like rivaroxaban. It is a disease with low incidence, few researches and no guidelines, so when and how to give anticoagulation remain controversial, especially during pregnancy. Further studies are necessary to give clues for clinical practicing of patients with this rare disease.

Antithrombin deficiency: A pediatric disorder

Incidence and features of thrombosis in children with inherited antithrombin deficiency

Inherited antithrombin deficiency caused by a mutation in the SERPINC1 gene: A case report

Analysis of phenotype and gene mutation in three pedigrees with inherited antithrombin deficiency

Molecular Basis and Thrombotic Manifestations of Antithrombin Deficiency in 15 Unrelated Chinese Patients.

Clinical and functional characterization of rare compound heterozygous mutations in the SERPINC1 gene causing severe thrombophilia

Genetic Analysis Should Be Included in Clinical Practice when Screening for Antithrombin Deficiency

Molecular Analysis of the Genotypes and Phenotypes in Three Pedigrees with Inherited Antithrombin Defidency

Compound Mutations in One Allele of AT Gene Causing Type I Inherited Antithrombin Deficiency

Identification and characterization of two SERPINC1 mutations causing congenital antithrombin deficiency

Atypical pulmonary thromboembolism caused by the mutation site SERPINC1 of the antithrombin III gene: A case report

Molecular Mechanisms of Antithrombin Deficiency in Two Chinese Families

Molecular Mechanisms of Antithrombin Deficiency Caused by Novel Double Heterozygous Mutations

SERPINC1 c.1247dupC: a novel SERPINC1 gene mutation associated with familial thrombosis results in a secretion defect and quantitative antithrombin deficiency

Rare Double Heterozygous Mutations in Antithrombin Underlie Hereditary Thrombophilia in a Chinese Family.

Antithrombin Deficiency Due to Heterozygous Antithrombin Gene Mutation and a Pedigree Study

Characterization of molecular defect of 13387-9delG mutated antithrombin in inherited type I antithrombin deficiency.

Antithrombin Therapy: Current State and Future Outlook

Inherited Antithrombin III Deficiency: A Case Report of Familial Pedigree and Gene Mutation Screening

Molecular mechanisms of recurrent venous thrombosis in two pedigrees with type I antithrombin deficiency]

A novel mutation in antithrombin gene results in hereditary antithrombin deficiency]